The Shimadzu-CGH Clinomics Centre (SC³) is a satellite clinical laboratory of Changi General Hospital (CGH) enabled with state-of-the-art mass spectrometry technology. SC³ focuses on developing clinical applications of improved diagnostic accuracy in order to provide better clinical care for patients with hypertension and other chronic diseases.

SC³ is a public-private partnership between CGH and Shimadzu (Asia Pacific). The partnership is a realisation of the advancement of healthcare and precision medicine leveraging translational analytical technology.